| |
| |
|
| Insider
Information: |
Onuscheck John Michael |
| Relationship: |
SVP & President, Europe |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
116,025 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,338,717 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
116,025 |
|
|
| Total
Value |
$8,338,717 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & President, Europe |
2015-01-01 |
116,025 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres-NeuromodulationOffi |
• – – |
2008-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,774 |
|
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2009-01-05 |
4 |
D |
$7.56 |
$1,724 |
D/D |
(228) |
9,595 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-01-04 |
4 |
D |
$9.01 |
$2,280 |
D/D |
(253) |
19,663 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-01-03 |
4 |
D |
$7.60 |
$1,923 |
D/D |
(253) |
30,761 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2009-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
588 |
9,823 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
588 |
19,916 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
588 |
31,014 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2009-02-13 |
4 |
D |
$8.66 |
$5,941 |
D/D |
(686) |
12,861 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-13 |
4 |
D |
$5.94 |
$4,116 |
D/D |
(693) |
47,978 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-02-16 |
4 |
D |
$7.41 |
$5,202 |
D/D |
(702) |
22,876 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2008-10-30 |
4 |
D |
$8.71 |
$6,480 |
D/D |
(744) |
9,235 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-11-01 |
4 |
D |
$6.32 |
$5,309 |
D/D |
(840) |
30,426 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2011-10-31 |
4 |
D |
$5.81 |
$4,880 |
D/D |
(840) |
44,730 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-05-09 |
4 |
D |
$7.71 |
$6,646 |
D/D |
(862) |
38,668 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• • – |
2012-10-30 |
4 |
D |
$5.17 |
$4,462 |
D/D |
(863) |
60,547 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2008-07-31 |
4 |
D |
$11.89 |
$12,033 |
D/D |
(1,012) |
6,880 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-05-07 |
4 |
D |
$6.31 |
$6,493 |
D/D |
(1,029) |
55,164 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2009-10-30 |
4 |
D |
$8.12 |
$8,510 |
D/D |
(1,048) |
19,328 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2009-05-07 |
4 |
D |
$8.79 |
$9,458 |
D/D |
(1,076) |
14,135 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-08-02 |
4 |
D |
$5.54 |
$6,338 |
D/D |
(1,144) |
28,976 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-08-01 |
4 |
D |
$6.92 |
$7,916 |
D/D |
(1,144) |
43,280 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• • – |
2012-07-31 |
4 |
D |
$5.17 |
$7,367 |
D/D |
(1,425) |
59,120 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-07-29 |
4 |
D |
$5.60 |
$8,562 |
D/D |
(1,529) |
27,002 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-07-29 |
4 |
D |
$7.16 |
$10,948 |
D/D |
(1,529) |
41,306 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2009-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,635 |
13,547 |
0 |
- |
|
79 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
